Senti Biosciences, Inc.
SNTI
$2.19
$0.083.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.88M | 48.61M | 10.84M | 15.95M | 23.82M |
| Total Receivables | 2.22M | 1.81M | 1.19M | 18.66M | 17.92M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.12M | 7.96M | 5.35M | 9.71M | 13.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 584.00K | 8.00K | 20.00K | -- |
| Total Current Assets | 45.21M | 58.96M | 17.38M | 44.34M | 55.67M |
|
|
|||||
| Total Current Assets | 45.21M | 58.96M | 17.38M | 44.34M | 55.67M |
| Net Property, Plant & Equipment | 33.94M | 35.24M | 36.69M | 38.55M | 40.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.63M | 3.64M | 3.65M | 4.02M | 6.37M |
| Total Assets | 82.78M | 97.84M | 57.72M | 86.91M | 102.19M |
|
|
|||||
| Total Accounts Payable | 1.56M | 1.45M | 793.00K | 1.18M | 1.62M |
| Total Accrued Expenses | 3.42M | 6.27M | 2.98M | 2.56M | 2.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.81M | 4.75M | 4.59M | 4.43M | 4.28M |
| Total Finance Division Other Current Liabilities | 934.00K | 671.00K | 704.00K | 896.00K | 973.00K |
| Total Other Current Liabilities | 934.00K | 671.00K | 704.00K | 896.00K | 973.00K |
| Total Current Liabilities | 10.73M | 13.15M | 9.06M | 9.07M | 9.61M |
|
|
|||||
| Total Current Liabilities | 10.73M | 13.15M | 9.06M | 9.07M | 9.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.63M | 28.89M | 30.12M | 31.31M | 32.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.56M | 5.05M | 2.54M | 2.39M | 4.04M |
| Total Liabilities | 44.92M | 47.09M | 41.73M | 42.77M | 46.09M |
|
|
|||||
| Common Stock & APIC | 349.11M | 322.78M | 312.52M | 311.81M | 312.55M |
| Retained Earnings | -311.25M | -297.13M | -296.52M | -267.66M | -256.46M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 37.86M | 25.65M | 15.99M | 44.15M | 56.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | 25.11M | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 25.11M | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.86M | 25.65M | 15.99M | 44.15M | 56.09M |
| Total Preferred Equity | -- | 25.11M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.86M | 50.76M | 15.99M | 44.15M | 56.09M |
|
|
|||||